Table 2 Most frequently prescribed drugs during the first year of follow-up in RSV patients and in the general population. Data are given as number and percentages (in brackets) for RSV patients and percentages for the general population
From: Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy
ATC code | Description | RSV patients (N = 1,378) | General population |
|---|---|---|---|
J01 | Antibacterials for systemic use | 998 (72.4%) | 50.7% |
R03 | Drugs for obstructive airway diseases | 966 (70.1%) | 29.8% |
H02 | Corticosteroids for systemic use | 282 (20.5%) | 14.5% |
A11 | Vitamins | 106 (7.7%) | 4.2% |
A02 | Drugs for acid related disorders | 59 (4.3%) | 0.5% |